文献速递糖尿病

Omnipod 5混合闭环系统对低血糖感知受损的1型糖尿病患者的影响

Effects of the Omnipod 5 Hybrid Closed-Loop System in People With Type 1 Diabetes With Impaired Awareness of Hypoglycemia.
PubMed 文献 · Diabetes Care · 2026-01-01

单中心研究纳入68例1型糖尿病患者(其中32例低血糖感知受损,Gold评分≥4),比较启动Omnipod 5混合闭环系统(OP5-HCL)前与12个月后的低血糖频率、持续时间及感知。结果显示OP5-HCL可降低低血糖感知受损患者的TBR和传感器检测低血糖事件数,但12个月后其低血糖负担仍显著高于感知正常者。

要点

  • OP5-HCL可减少低血糖感知受损患者的TBR和低血糖事件数。
  • 12个月后低血糖感知受损患者TBR和事件数仍高于感知正常者。
  • 低血糖感知受损患者基线低血糖持续时间显著长于感知正常者。

核心结论

  • OP5-HCL降低低血糖感知受损患者的TBR和传感器检测低血糖事件数,但12个月后其低血糖负担仍显著高于感知正常者。

研究设计与样本

  • 单中心研究,纳入68例1型糖尿病患者(73.5%女性,平均年龄38.0±15.6岁,糖尿病病程21.0±13.5年)。
  • 低血糖感知受损组32例(Gold评分≥4),与年龄性别匹配的感知正常对照组32例(Gold评分≤2)比较。
  • 分析基线及启动OP5-HCL后12个月的28天CGM数据,评估每周传感器检测低血糖(SDH)和血糖指标。

主要发现

  • 基线时,低血糖感知受损组TBR(<3.9 mmol/L)和SDH事件数均显著高于感知正常组。
  • 低血糖感知受损组基线低血糖(<3.9 mmol/L)中位持续时间显著更长(33.5 vs. 24.5 min;P=0.007)。
  • 启动OP5-HCL后,低血糖感知受损组TBR从2.8%降至1.7%(P=0.024),SDH3.9事件数从5.4降至4.0(P=0.026)。
  • 12个月后,低血糖感知受损组TBR(1.7% vs. 0.7%;P=0.007)和SDH3.9事件数(4.0 vs. 2.0;P=0.013)仍显著高于感知正常组。
  • 12个月后两组低血糖持续时间差异不再显著(29.8 vs. 28.0 min;P=0.084)。

临床怎么用

  • 对于低血糖感知受损的1型糖尿病患者,OP5-HCL可减少低血糖暴露和事件数,但仍需关注残余低血糖负担。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the real-world impact of initiating Omnipod 5 hybrid closed-loop (OP5-HCL) system on hypoglycemia frequency, duration, and awareness in people with type 1 diabetes and impaired awareness of hypoglycemia (IAH). RESEARCH DESIGN AND METHODS: A single-center study of people with type 1 diabetes and IAH (Gold score ≥4) with outcomes compared at baseline and 12 months after OP5-HCL initiation. The 28-day CGM data were analyzed to provide weekly sensor-detected hypoglycemia (SDH) data and glycemic metrics at baseline and 12 months. Outcomes of those with IAH were compared with age- and sex-matched control participants with normal awareness of hypoglycemia (NAH) (Gold score ≤2). RESULTS: The study included 68 individuals (73.5% female; mean ± SD age 38.0 ± 15.6 years; and diabetes duration 21.0 ± 13.5 years). At baseline, people with IAH (n = 32) experienced both significantly higher time below range (TBR) (<3.9 mmol/L) and more episodes of SDH compared with those with NAH (n = 32). The IAH group also experienced a significantly longer median duration of hypoglycemia episodes below 3.9 mmol/L (SDH3.9) (33.5 vs. 24.5 min; P = 0.007). Initiation of OP5-HCL resulted in a decrease in TBR (from 2.8% to 1.7%; P = 0.024) and number of SDH3.9 episodes (from 5.4 to 4.0; P = 0.026). After 12 months of OP5-HCL use, the hypoglycemia burden experienced by those with IAH remained higher, including TBR (1.7% vs. 0.7%; P = 0.007) and number of SDH3.9 episodes (4.0 vs. 2.0; P = 0.013), but the difference in episode duration was no longer significant (29.8 vs. 28.0 min; P = 0.084). CONCLUSIONS: Use of OP5-HCL by people with IAH reduced TBR and the number of episodes of SDH. However, the overall hypoglycemia burden remained significantly higher in those with IAH.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Goodman IR, Berry SA, McNally EH, et al. Effects of the Omnipod 5 Hybrid Closed-Loop System in People With Type 1 Diabetes With Impaired Awareness of Hypoglycemia. Diabetes Care. 2026. PMID: 42429743. doi:10.2337/dc26-0422

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。